Similarly, a retrospective study by Kheir and colleagues found that higher albumin levels on admission were associated with a lower incidence of adverse outcomes, including venous thromboembolism (VTE), acute respiratory distress syndrome (ARDS) development, and intensive care unit (ICU) stay in COVID-19 patients [29]. This evidence concerns the gene ALB and COVID-19.